CCL2 and polycystic ovary syndrome: PCOS females have significantly increased levels of MCP-1 [14], and clinical studies have shown that supplementation with omega-3 PUFAs is beneficial in decreasing MCP-1 expression in macrophages and the levels of endothelial chemokines [52, 53].